Migracins A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp.

Yuhei Arai, Hironobu Iinuma, Yoko Ikeda, Masayuki Igarashi, Masaki Hatano, Naoko Kinoshita, Tamami Ukaji, Siro Simizu, Kazuo Umezawa

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

In the course of screening for breast cancer cell migration inhibitors, we isolated two novel compounds, migracins A and B from the culture broth of Streptomyces sp. MI264-NF2. Their structures are related to those of luminacins previously isolated from Streptomyces. Migracins A and B inhibited breast cancer cell migration, monitored by wound healing assay with IC 50 values of 1.31 and 1.99 μg ml -1, respectively, in human breast carcinoma MDA-MB-231 cells without showing any cytotoxicity. Migracins also inhibited the migration of human lung adenocarcinoma A549 cells and human fibrosarcoma HT-1080 cells. Therefore, migracins may become new cancer metastasis inhibitors.

Original languageEnglish
Pages (from-to)225-230
Number of pages6
JournalJournal of Antibiotics
Volume66
Issue number4
DOIs
Publication statusPublished - 2013 Apr

Fingerprint

Streptomyces
Cell Movement
Breast Neoplasms
Neoplasms
Fibrosarcoma
Wound Healing
Neoplasm Metastasis
migracin A
migracin B

Keywords

  • Breast carcinoma
  • Cancer cell migration
  • Luminacin
  • Migracin
  • Streptomyces sp.

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Arai, Y., Iinuma, H., Ikeda, Y., Igarashi, M., Hatano, M., Kinoshita, N., ... Umezawa, K. (2013). Migracins A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp. Journal of Antibiotics, 66(4), 225-230. https://doi.org/10.1038/ja.2012.112

Migracins A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp. / Arai, Yuhei; Iinuma, Hironobu; Ikeda, Yoko; Igarashi, Masayuki; Hatano, Masaki; Kinoshita, Naoko; Ukaji, Tamami; Simizu, Siro; Umezawa, Kazuo.

In: Journal of Antibiotics, Vol. 66, No. 4, 04.2013, p. 225-230.

Research output: Contribution to journalArticle

Arai, Y, Iinuma, H, Ikeda, Y, Igarashi, M, Hatano, M, Kinoshita, N, Ukaji, T, Simizu, S & Umezawa, K 2013, 'Migracins A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp.', Journal of Antibiotics, vol. 66, no. 4, pp. 225-230. https://doi.org/10.1038/ja.2012.112
Arai, Yuhei ; Iinuma, Hironobu ; Ikeda, Yoko ; Igarashi, Masayuki ; Hatano, Masaki ; Kinoshita, Naoko ; Ukaji, Tamami ; Simizu, Siro ; Umezawa, Kazuo. / Migracins A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp. In: Journal of Antibiotics. 2013 ; Vol. 66, No. 4. pp. 225-230.
@article{33a6733d9bed4a9e9dcdc60b5d4ed4e4,
title = "Migracins A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp.",
abstract = "In the course of screening for breast cancer cell migration inhibitors, we isolated two novel compounds, migracins A and B from the culture broth of Streptomyces sp. MI264-NF2. Their structures are related to those of luminacins previously isolated from Streptomyces. Migracins A and B inhibited breast cancer cell migration, monitored by wound healing assay with IC 50 values of 1.31 and 1.99 μg ml -1, respectively, in human breast carcinoma MDA-MB-231 cells without showing any cytotoxicity. Migracins also inhibited the migration of human lung adenocarcinoma A549 cells and human fibrosarcoma HT-1080 cells. Therefore, migracins may become new cancer metastasis inhibitors.",
keywords = "Breast carcinoma, Cancer cell migration, Luminacin, Migracin, Streptomyces sp.",
author = "Yuhei Arai and Hironobu Iinuma and Yoko Ikeda and Masayuki Igarashi and Masaki Hatano and Naoko Kinoshita and Tamami Ukaji and Siro Simizu and Kazuo Umezawa",
year = "2013",
month = "4",
doi = "10.1038/ja.2012.112",
language = "English",
volume = "66",
pages = "225--230",
journal = "Journal of Antibiotics",
issn = "0021-8820",
publisher = "Japan Antibiotics Research Association",
number = "4",

}

TY - JOUR

T1 - Migracins A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp.

AU - Arai, Yuhei

AU - Iinuma, Hironobu

AU - Ikeda, Yoko

AU - Igarashi, Masayuki

AU - Hatano, Masaki

AU - Kinoshita, Naoko

AU - Ukaji, Tamami

AU - Simizu, Siro

AU - Umezawa, Kazuo

PY - 2013/4

Y1 - 2013/4

N2 - In the course of screening for breast cancer cell migration inhibitors, we isolated two novel compounds, migracins A and B from the culture broth of Streptomyces sp. MI264-NF2. Their structures are related to those of luminacins previously isolated from Streptomyces. Migracins A and B inhibited breast cancer cell migration, monitored by wound healing assay with IC 50 values of 1.31 and 1.99 μg ml -1, respectively, in human breast carcinoma MDA-MB-231 cells without showing any cytotoxicity. Migracins also inhibited the migration of human lung adenocarcinoma A549 cells and human fibrosarcoma HT-1080 cells. Therefore, migracins may become new cancer metastasis inhibitors.

AB - In the course of screening for breast cancer cell migration inhibitors, we isolated two novel compounds, migracins A and B from the culture broth of Streptomyces sp. MI264-NF2. Their structures are related to those of luminacins previously isolated from Streptomyces. Migracins A and B inhibited breast cancer cell migration, monitored by wound healing assay with IC 50 values of 1.31 and 1.99 μg ml -1, respectively, in human breast carcinoma MDA-MB-231 cells without showing any cytotoxicity. Migracins also inhibited the migration of human lung adenocarcinoma A549 cells and human fibrosarcoma HT-1080 cells. Therefore, migracins may become new cancer metastasis inhibitors.

KW - Breast carcinoma

KW - Cancer cell migration

KW - Luminacin

KW - Migracin

KW - Streptomyces sp.

UR - http://www.scopus.com/inward/record.url?scp=84877295070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877295070&partnerID=8YFLogxK

U2 - 10.1038/ja.2012.112

DO - 10.1038/ja.2012.112

M3 - Article

C2 - 23232932

AN - SCOPUS:84877295070

VL - 66

SP - 225

EP - 230

JO - Journal of Antibiotics

JF - Journal of Antibiotics

SN - 0021-8820

IS - 4

ER -